Health Catalyst, Inc. (HCAT)

NasdaqGS: HCAT · 即時價格 · USD

1.69

-0.02 (-1.17%)

收盤價： Sep 04, 2026, 3:59 PM

1.64

-2.96%

盤後: 7:30 PM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

-1.17% (1D)

買價	1.21
市值	127M
營收 (ttm)	292M
淨利（ttm）	-265M
	1.53
	-3.67
	n/a
	215.29
P/B (ttm)	1.25
P/S (ttm)	0.44
財報日期	Aug 5, 2021

賣價	2.05
成交量	400,422
20 日平均成交量	1,137,759
開盤價	1.68
前收盤價	1.71
當日區間	1.67 - 1.71
52 週範圍	0.95 - 3.62
分析師	n/a
目標價	1.9 (12.43%)
股利	n/a
除息日	n/a

關於 HCAT

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform ...

[閱讀更多]

產業 Health Information Services

類股 Healthcare

IPO 日期 Jul 25, 2019

員工 1,200

證券交易所 NasdaqGS

股票代號 HCAT

網站 https://www.healthcatalyst.com

完整的公司簡介

財務表現

Health Catalyst 在 2025 年的營收為 311.14M，較前一年的 306.58M 增加 1.48%。淨利為 -177.97M，較前期增加 156.07%。

財務報表

分析師預測

根據 4 位分析師的評等，HCAT 的平均評等為「null」。12 個月目標價為 1.9，較最新價格有 12.43% 的上漲空間。

股票預測

財報驚奇

Health Catalyst 已於 Aug 6, 2026 公布季度財報：

營收為 $70.49M 低於預期 $0, 年增 -12.68% 下滑.
每股盈餘為 0.04 超出預期 0.01, 年增 0.00% 成長.

下次財報發布

Health Catalyst, Inc. 的下次財報預計於 Aug 5, 2021, 收盤後。
分析師預估營收 ... 升級

價格為何變動

新聞動態

2 週前 · StockStory

Health Catalyst, GitLab, Elastic, and Marqeta Shares Plummet, What You Need To Know

A number of stocks fell in the afternoon session after Bloomberg reported that Anthropic’s preliminary second-quarter revenue topped $11.5 billion.

2 週前 · StockStory

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other busine...

2 週前 · StockStory

5 Must-Read Analyst Questions From Health Catalyst’s Q2 Earnings Call

Health Catalyst’s second quarter was marked by a notable decline in sales, which management attributed primarily to the ongoing impact of client migrations and a reduction in lower-margin services. Th...

3 週前 · Motley Fool

Health Catalyst (HCAT) Q2 2026 Earnings Call Transcript

Company divests Vitalware for $147M, retires $160M debt amid platform migration.

3 週前 · StockStory

HCAT Q2 Deep Dive: Vitalware Divestiture Reshapes Strategy Amid Revenue Decline

Healthcare data analytics company Health Catalyst (NASDAQ:HCAT) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, but sales fell by 12.7% year on year to $70.49 million. On the other ...

第 1 頁，共 2 頁

Health Catalyst, Inc. (HCAT)